Page 32 - book

Type Product Dosage form Strength Indication Status IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

ROSUVASTATIN TABLET ORAL TAB/30 5 mg Hyper Lipidemia active

ROSUVASTATIN TABLET ORAL TAB/30 10 mg hyper Lipidemia active

ROSUVASTATIN TABLET ORAL TAB/30 20 mg Hyper Lipidemia active

ROSUVASTATIN TABLET ORAL TAB/30 40 mg Hyper Lipidemia active

MESALAZINE TABLET, DELAYED RELEASE TAB/30 500 mg IBD active
ORAL
VARENICLINE TARTRATE TABLET ORAL TAB/56 1 mg Smoking Cessation active

VARNECLINE TABLET TAB/25 0.5+1 mg Smoking Cessation active

ACAMPROSATE TABLET, DELAYED RE- TAB/168 300 mg Alcoholism active
LEASE ORAL
LEVODOPA / BENSERAZIDE TABLET TAB/30 100 mg/25 mg Parkinson’s disease active
ORAL
GENERAL LEVODOPA / BENSERAZIDE TABLET TAB/30 200 mg/50 mg Parkinson’s disease active
ORAL

DAPOXETINE (AS HYDROCHLORIDE) TAB/6 30 mg Premature ejacu- active
TABLET ORAL lation
DAPOXETINE (AS HYDROCHLORIDE) TAB/6 60 mg Premature ejacu- active
TABLET ORAL lation

Heart and blood
BISOPROLOL FUMARATE TABLET ORAL TAB/30 2.5 mg active
pressure
BISOPROLOL FUMARATE TABLET ORAL TAB/30 5 mg Heart and blood active
pressure
Heart and blood
BISOPROLOL FUMARATE TABLET ORAL TAB/30 10 mg active
pressure
METRONIDAZOLE TABLET ORAL TAB/100 250 mg Antibiotic active

METRONIDAZOLE TABLET ORAL TAB/20 500 mg Antibiotic active
HYOSCINE-N-BUTYL BROMIDE TABLET TAB/100 10 mg Gastrointestinal active
ORAL
disorders active 40 mg blood pressure active

31
you can find the rest of the product list on page 156